NFKB1 and metabolic disease: The inhibitory effects of SIRT1 on the NF-κB signaling pathway can significantly alleviate chronic inflammatory responses in tissues and exert important protective effects in metabolic diseases such as insulin resistance and atherosclerosis, as well as in inflammation-related diseases.